For most private companies, the decision to list on a public exchange has looked unattractive for the better part of a decade. Private capital has been abundant, compliance costs have been rising, and the window for a successful IPO has been narrow and selective. That calculation has now started to shift, and directors who have not revisited the question in three years are working from an outdated framework.
Three developments in the twelve months to March 2026 are material. The Australian Securities and Investments Commission has opened a fast-track IPO trial for a limited category of issuers. The private capital markets, which absorbed most of the companies that might otherwise have listed, have tightened for mid-sized deals. And the Texas Stock Exchange has opened as a credible offshore alternative for Australian issuers with US commercial exposure.
The ASIC fast-track IPO trial
The fast-track pathway operates on shorter prospectus review timelines and reduced procedural steps for issuers that meet defined criteria. The intention is to bring Australian issuance costs and timelines closer to comparable markets.
The structural question is not whether to list, but whether the conditions that made listing unattractive in 2022 still hold in 2026. For many boards, they do not. Anthony Jarvis, Opportuna Legal
The private capital position
Private capital remains available, but the terms on offer for mid-sized raises have moved. Boards evaluating a Series C or later round should compare the dilution, liquidity, and governance implications of continued private funding against an IPO.
Valuation considerations
Public market valuations reflect comparable trading multiples and often differ from private round valuations by a meaningful margin, in both directions.
Liquidity for existing shareholders
A listing creates an orderly liquidity path for founders, early employees, and long-standing investors that private rounds rarely match.
IPO Readiness Checklist
A 12-page checklist covering governance, financial reporting, legal, and capital structure readiness for a 2026 listing.
The Texas Stock Exchange alternative
The Texas Stock Exchange has become a live option for Australian companies with material US revenue or customer exposure. Its listing standards are comparable to the major US exchanges, and its costs are lower. For a subset of Australian issuers, a TXSE listing offers advantages that neither the ASX nor NASDAQ match.
When the timing matters
Listing windows are narrow. The firm's name, Opportuna, reflects the commercial reality that timing and preparation are inseparable. Boards considering a 2026 or 2027 listing should be running the preparation work now.
What Opportuna Legal advises on
Opportuna Legal advises boards, founders, and existing shareholders on IPO readiness and execution across ASX, TXSE, and NASDAQ pathways. Work typically covers capital structure, shareholder agreement reconciliation, governance uplift, prospectus preparation, and coordination with corporate advisers and underwriters.
To discuss whether a listing is the right commercial path for your company in 2026, contact the firm directly.